Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Pharmaceutical industry trends


OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

   by Marina Gonzalo    125
OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

Cambridge, UK, 19 June 2020 - OKRA, a leading provider of Artificial Intelligence (AI) driven analytics for Life Sciences, today hit an important milestone, delivering 2 million validated predictions so far in 2020, smashing through its yearly target in just half the expected time. This underscores OKRA’s achievements in empowering the pharmaceutical industry with explainable, real-time AI solutions.

Arena International Announces the Brand New Direct-to-Patient and Virtual Clinical Trials Digital Experience

   by Kadin Luong    83
Arena International Announces the Brand New Direct-to-Patient and Virtual Clinical Trials Digital Experience

London – Arena International announced today the first-ever Direct-to-Patient and Virtual Clinical Trials (https://arena-international.com/dtpvirtual/) will be held as a Digital Experience on Thursday, 9 July 2020. As COVID-19 has forced the market to move towards decentralized and remote models, this event provides the perfect opportunity for clinical trial professionals to hear, meet and learn from top-class speakers around the world to discuss challenges and innovations in this critical time.

13 Life Science Blogs To Follow

   by BiopharmaTrend    7086
13 Life Science Blogs To Follow

We have decided to summarize a list of niche blogs, mostly personal, run by the Life Science professionals - scientists, business leaders. Such blogs often provide personalized insights into certain areas of drug discovery, biotech, and business, which are not properly covered by the mainstream media, or covered in very general strokes. Reading blogs is a great way to explore nuances of the industry -- through the prism of personal opinions and experiences of the authors. 

(Blogs are listed in alphabetical order).

Exyte and Univercells Technologies Combine Аorces for Rapid Deployment of Vaccine Production Plants in the Wake of the COVID-19 Pandemic

   by White Matter Communications    148
  • Exyte offers the new ExyCellR modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing practice (cGMP).
  • Univercells Technologies delivers the integrated NevoLine™ biomanufacturing platform, including scale-X™ bioreactors, for low footprint and economic large-scale production of viral products.
  • The combined offer enables users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to new disease outbreaks.

Paving A Pathway To Pharma 4.0

   by Cathal Strain    536
Paving A Pathway To Pharma 4.0

Pharmaceutical manufacturers find themselves at a critical juncture. In the past 30 years, pharma has seen some significant shifts. Consider the expanding range of drug therapies, once confined almost exclusively to small molecule drugs. Biologics now comprise a substantial share of the market, and novel treatments such as cell and gene therapies are rapidly gaining traction. Another major trend is the rise of outsourced manufacturing, primarily for small molecule drugs.